Recent regulatory changes regarding delta-9-tetrahydrocannabinol (Δ9-THC) content in hemp seed products have ushered in a new era in industry regulation. Commission Regulation (EU) 2022/1393, published on August 12, 2022, introduces strict standards on maximum levels of Δ9-THC, which are to enter into force from January 1, 2023. These regulations apply not only to Δ9-THC but also to delta-9-tetrahydrocannabinolic acid (Δ9-THCA), with conversion to Δ9-THC equivalent using a conversion factor of 0,877.
Under the new regulations, the maximum permissible levels of Δ9-THC are 3 mg/kg for hemp seeds and products derived from them, except for hemp seed oil, for which the limit is 7 mg/kg. These regulations aim to increase consumer safety and reduce the presence of psychoactive substances in food products, forcing producers and suppliers to adapt their production processes and quality control systems.
Delta-9-tetrahydrocannabinol, the key psychoactive ingredient of cannabis, is a chemical compound from the cannabinoid family. Its structure includes three cyclic rings and a side chain, and its pharmacological action involves interaction with cannabinoid receptors in the nervous system, which affects a variety of physiological processes.
These interactions can lead to psychoactive effects such as altered perception, euphoria, reduced pain perception, effects on memory and cognition. THC is also under investigation for its potential therapeutic uses, despite concerns about its psychoactive effects and possible long-term effects.
The new regulations introduce challenges for the industry, while emphasizing the importance of adapting to dynamically changing regulations. For detailed information please visit consultation with the full text of the regulation available on the website of the Chief Sanitary Inspectorate, which will allow for better understanding and preparation for the upcoming changes.